| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 133.522 | 565.757 | 1.179.028 | 2.297.982 | 3.345.114 | 4.282.841 | 5.834.329 |
| Total Income - EUR | - | - | 0 | 133.522 | 571.535 | 1.195.188 | 2.307.381 | 3.345.125 | 4.282.851 | 5.834.570 |
| Total Expenses - EUR | - | - | 0 | 167.013 | 526.053 | 1.067.110 | 2.219.140 | 3.254.509 | 4.253.205 | 5.435.873 |
| Gross Profit/Loss - EUR | - | - | 0 | -33.490 | 45.482 | 128.078 | 88.240 | 90.616 | 29.646 | 398.697 |
| Net Profit/Loss - EUR | - | - | 0 | -34.816 | 39.821 | 115.338 | 72.033 | 78.462 | 18.908 | 343.532 |
| Employees | - | - | 0 | 7 | 12 | 17 | 32 | 44 | 68 | 86 |
Check the financial reports for the company - Rmn Diagnostic Si Tratament Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 9 | 2.057 | 79.882 | 129.714 | 282.838 | 312.622 | 596.019 |
| Current Assets | - | - | 0 | 2.372 | 69.822 | 162.120 | 222.047 | 296.260 | 577.780 | 848.491 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 1.761 | 9.315 |
| Receivables | - | - | 0 | 0 | 56.261 | 102.375 | 177.713 | 268.933 | 564.374 | 649.518 |
| Cash | - | - | 0 | 2.372 | 13.561 | 59.745 | 44.334 | 27.327 | 11.645 | 189.658 |
| Shareholders Funds | - | - | 0 | -34.773 | 7.808 | 122.998 | 192.344 | 271.403 | 265.695 | 607.113 |
| Social Capital | - | - | 0 | 43 | 42 | 41 | 81 | 81 | 81 | 80 |
| Debts | - | - | 0 | 37.154 | 64.346 | 120.214 | 161.294 | 310.695 | 630.178 | 844.954 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Rmn Diagnostic Si Tratament Srl